Rennova Health Inc (RNVA)

[nfrequent]

Breakout from the 000s inevitable. The CAH fixed-cost reimbursement model has been proven out in Rennova Healthcare, Inc.'s two years of dynamic revenue and earnings growth. Cost of revenue falling off the other side of the P/L, including interest on debt reduced. CAH adds a great deal of certainty in revenue and earnings trend.

Preferred share warrants on 400 billion common shares expired. Corporate equity buybacks at a major discount of the other 100 billion locked in at .0001 no matter how high the market price rises. Now on track to NYSE listing (as RHCI maybe?).

WTF?